Sarah Kathryn Rouan Navidea Biopharmaceuticals, Inc. (NAVB) insider trading activity

NAVB Quotes by TradingView

Sarah Kathryn Rouan is Director of NAVIDEA BIOPHARMACEUTICALS, INC.. Currently has a direct ownership of 18,242 shares of NAVB, which is worth approximately $0. The most recent transaction as insider was on Jun 30, 2021, when has been sold 4,892 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.2K
0% 3M change
0% 12M change
Total Value Held $0

Sarah Kathryn Rouan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2021
BUY
Grant, award, or other acquisition
-
4,892 Added 21.15%
18,242 Common Stock
Jan 13 2021
BUY
Grant, award, or other acquisition
-
2,500 Added 15.77%
13,350 Common Stock

Also insider at

VKTX
Viking Therapeutics, Inc. Healthcare
Director
SKR

Sarah Kathryn Rouan

Director
San Diego, CA

Track Institutional and Insider Activities on NAVB

Follow NAVIDEA BIOPHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NAVB shares.

Notify only if

Insider Trading

Get notified when an Navidea Biopharmaceuticals, Inc. insider buys or sells NAVB shares.

Notify only if

News

Receive news related to NAVIDEA BIOPHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NAVB